MRKR Stock Analysis: Buy, Sell, or Hold?
MRKR - Marker Therapeutics, Inc. Common Stock
$1.59
-0.01 (-0.63%)
▼
5d:
-14.97%
30d:
+6.71%
90d:
+61.01%
WAIT
LOW Confidence
Last Updated: January 30, 2026
Get Alerted When MRKR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MRKR is down 15.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MRKR is down 15.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MRKR is currently trading at $1.59, which is considered slightly high relative to its 30-day fair value range of $1.44 to $2.03.
Technical Outlook: Technically, MRKR is in a strong uptrend. The price is currently testing key support at $1.58. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.87 (+391.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MRKR is in a strong uptrend. The price is currently testing key support at $1.58. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.87 (+391.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$1.44 -
$2.03
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.8%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 391.7% below Wall St target ($7.87)
- WARNING: Recommendation downgraded due to -15.0% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.44 -
$2.03
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.58
Resistance Level
$2.29
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.03
Wall Street Target
$7.87
(+391.7%)
Revenue Growth (YoY)
-36.0%
Last updated: February 02, 2026 9:18 AM ET
Data refreshes hourly during market hours. Next update: 10:18 AM
Data refreshes hourly during market hours. Next update: 10:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MRKR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 55 HOLD |
